Literature DB >> 22535262

The role of gender in primary hyperparathyroidism: same disease, different presentation.

Haggi Mazeh1, Rebecca S Sippel, Herbert Chen.   

Abstract

BACKGROUND: Hyperparathyroidism is much more common in women and therefore may represent different diseases in men and women. In order to understand the role of gender in hyperparathyroidism, we reviewed our experience.
METHODS: We analyzed a prospective database of 1309 consecutive patients with primary hyperparathyroidism who underwent parathyroidectomy at our institution between March 2001 and August 2010.
RESULTS: The female-to-male ratio was 3.3:1, and female patients were older at presentation (60 ± 0 vs. 57 ± 1 years, p < 0.005). Male patients were more commonly asymptomatic at presentation (25 % vs. 18 %, p = 0.005) and the most common symptom for men was kidney stones (23 % vs. 13 %, p < 0.0001). For patients with bone density scans, osteoporosis was more common in women (34 % vs. 17 %, p < 0.0001). Men had a slightly higher preoperative serum calcium level (11.1 ± 0 vs. 11.0 ± 0 mg/dl, p = 0.03), higher parathyroid hormone level (140 ± 7 vs. 124 ± 4 pg/ml, p = 0.04), higher urinary calcium level (376 ± 10 vs. 314 ± 5 mg/24 h, p < 0.005), and lower vitamin D level (28 ± 1 vs. 32 ± 0 ng/ml, p < 0.005). Men were more likely to have abnormally elevated creatinine values (15 % vs. 9 %, p = 0.004). The operative approach as well as the number of glands involved and their location did not significantly differ between the groups. The mean gland weight for a single adenomas was higher in male patients (1123 ± 128 vs. 636 ± 32 mg, p = 0.001). No significant difference was identified in the immediate and remote postoperative course.
CONCLUSIONS: Hyperparathyroidism appears to present differently depending on gender. Male patients more often present without symptoms, present with vitamin D deficiency, and have larger parathyroid glands. Importantly, surgical outcomes were equivalent between men and women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535262     DOI: 10.1245/s10434-012-2378-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism.

Authors:  W Wang; M Nie; Y Jiang; M Li; X Meng; X Xing; O Wang; W Xia
Journal:  Osteoporos Int       Date:  2019-10-23       Impact factor: 4.507

3.  Correlation between biochemical features and outcomes of preoperative imaging (SPECT-CT and Ultrasound) in primary hyperparathyroidism.

Authors:  H Anderson; K H Lim; D Simpson; S Gull; R Oprean; F Lee; C Kakos; I T Cvasciuc
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

4.  High parathyroid hormone levels after parathyroidectomy for parathyroid adenoma are not related to the cellularity of the remaining glands.

Authors:  Rotem Sagiv; Bertha Delgado; Re'em Sadeh; Sagi Shashar; Merav Fraenkel; Ksenia M Yegodayev; Moshe Elkabets; Ben-Zion Joshua
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-08

5.  Primary hyperparathyroidism in Saudi Arabia revisited: a multi-centre observational study.

Authors:  Yousef Al-Saleh; Abdullah AlSohaim; Reem AlAmoudi; Ali AlQarni; Raed Alenezi; Layla Mahdi; Hend Alzanbaqi; Samah M Nawar; Hibah AlHarbi; Abdulrhman ALMulla; Maryam Al Qahtani; Salih Bin Salih; Faisal Al Anazi; Najla Saleh; Seham Saleh; Ali AlAklabi; Shaun Sabico; Nasser M Al-Daghri
Journal:  BMC Endocr Disord       Date:  2022-06-09       Impact factor: 3.263

6.  Do giant parathyroid adenomas represent a distinct clinical entity?

Authors:  Philip M Spanheimer; Andrew J Stoltze; James R Howe; Sonia L Sugg; Geeta Lal; Ronald J Weigel
Journal:  Surgery       Date:  2013-08-23       Impact factor: 3.982

7.  Longitudinal Assessment of PTH in Community-Dwelling Older Women-Elevations Are Not Associated With Mortality.

Authors:  David Buchebner; Linnea Malmgren; Anders Christensson; Fiona McGuigan; Paul Gerdhem; Martin Ridderstråle; Kristina Åkesson
Journal:  J Endocr Soc       Date:  2017-04-19

8.  Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidism.

Authors:  Danica M Vodopivec; Angelica M Silva; Dinamarie C Garcia-Banigan; Ioannis Christakis; Ashley Stewart; Kelly Schwarz; Caroline S Hussey; Roland Bassett; Mimi I Hu; Nancy D Perrier
Journal:  Endocrinol Diabetes Metab       Date:  2018-09-04

9.  The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records.

Authors:  F Hamilton; R Carroll; W Hamilton; C Salisbury
Journal:  Br J Cancer       Date:  2014-08-05       Impact factor: 7.640

Review 10.  Gender Predilection in Sporadic Parathyroid Adenomas.

Authors:  Maria P Yavropoulou; Athanasios D Anastasilakis; Argyro Panagiotakou; Evanthia Kassi; Polyzois Makras
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.